March 22, 2016 / 12:43 PM / in 2 years

BRIEF-Knight therapeutics says Profounda inc launches Impavido in the U.S.

March 22 (Reuters) - Knight Therapeutics Inc

* Says U.S. Commercialization partner, profounda inc has launched Impavido (miltefosine) in united states Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below